July 23- Tupperware Brands Corp, known for its colorful food containers, cut its full-year sales and profit forecast, citing lower sales in Europe. The company, whose shares fell as much as 11 percent, also reported lower-than-expected sales for the second quarter ended June 28 due to poor demand in Germany.
*Apple rallies after results, boosting tech names. NEW YORK, July 23- U.S. stocks were largely higher on Wednesday, with the S&P 500 hitting another record high after bullish results from tech giants Apple and Microsoft, though technical resistance and conflicts in Ukraine and the Gaza Strip kept gains in check.
WASHINGTON, July 23- The International Monetary Fund on Wednesday said it expects the U.S. economy to grow 1.7 percent in 2014, even more slowly than it predicted a month ago, as weakness in the first quarter offsets an expected pick-up in the second half of the year.
CNBC's Phil LeBeau breaks down the numbers on Boeing's quarterly results, and explains why the stock is sinking.
CNBC's Dominic Chu takes a look at the big movers in biotech on Wednesday.
*Adjusted profit $1.04 a share vs estimate of $1.03. July 23- Delta Air Lines reported a higher-than-expected second-quarter profit as it flew fuller planes and enjoyed higher passenger revenue in the United States, boosting its shares by 3 percent.
Citi's Jim Suva, provides his read on Apple, as the tech giant prepares to debut the iPhone 6. We think this is going to be the best product out there, says Suva.
July 23- Boeing Co reported a 52 percent jump in quarterly profit, helped by higher commercial plane deliveries and one-time tax gains, but investors were spooked by rising costs in its military tanker program.
CNBC's Phil LeBeau breaks down the numbers on Delta and Boeing. Also a look at what to expect from the high-flying airline sector as the S&P Transports hit all-time highs for the second day in a row.
July 23- PepsiCo Inc's higher-than-expected quarterly profit could give the company more ammunition against an activist investor who wants it to separate its snack and beverage businesses. The sales increases were partly a result of price hikes that PepsiCo implemented as it launched new products which usually command higher prices.
Ben Lerer, Thrillist Media Group co-founder & CEO, explains why he is a big believer of Facebook and says it's the best source of users for his company.
It's a big week for momentum stocks, reports CNBC's Seema Mody, with a look at tech stocks reporting earnings this week.
WASHINGTON— U.S. economic growth this year will likely be at the weakest pace since the Great Recession ended, the International Monetary Fund said, mostly because of a sharp, weather-related contraction in the first quarter. That's below last year's 1.9 percent pace and would be the slowest annual rate since the recession ended in June 2009.
CNBC's Meg Tirrell speaks to Dr. George Scangos, Biogen Idec CEO, about the company's Q2 earnings surge, drug pipeline, and America's tax code. Scangos says we need a corporate tax rate that is competitive with rest of the world and a territorial tax system.
Jon Steinberg, Daily Mail North America CEO, and Jessica Lessin, The Information editor in chief, discuss Apple's earnings and competition in the tablet market. Steinberg says the 9-percent drop in iPad sales is "brutal."
IMF CUTS U.S. 2014 GROWTH FORECAST TO 1.7 PCT FROM JUNE FORECAST OF 2 PCT DUE TO FIRST-QUARTER GROWTH REVISION.
Roger McNamee, Elevation Partners co-founder; investor Kevin O'Leary, and the "Squawk Alley" crew, discuss the better fit to buy Time Warner: Google or 21st Century Fox.
Investor Kevin O'Leary of "Shark Tank;" Roger McNamee, Elevation Partners co-founder; and the "Squawk Alley" crew, discuss Apple's earnings. McNamee says the IBM deal is key and explains the "big problem" with the iPad.
Thirteen stocks in the S&P 500 are targeting 60 percent rises in stock prices...but is it too ambitious? USAToday reports.
LONDON, July 23- GlaxoSmithKline cut its 2014 earnings outlook after sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.